AAI Pharma Files Lawsuit Against Dr. Reddy's Laboratories

by Medindia Content Team on  January 17, 2002 at 10:57 AM Drug News   - G J E 4
AAI Pharma Files Lawsuit Against Dr. Reddy's Laboratories
Dr. Reddy's Laboratories (DRL) has been slapped with a lawsuit for patent infringement by the US based AAI Pharma Inc for the generic version of the anti-depressant drug Prozac. DRL has a 180 days exclusivity to sell the drug's 40 mg dosage form along with Barr Laboratories that holds the exclusivity for the 10 and 20 mg dosage forms. DRL expects this to be a routine move as the para IV filing after the patent expiry allows the patent holder to file a lawsuit to challenge the generic player's entry.

AAI Pharma has 2 patents on Fluoxetine approved in July 2001 after the 180 exclusivity was granted to DRL and Barr Laboratories. Pharmaceutical Resources Inc is Dr Reddy's marketing partner for Fluoxetine in the US. Eli Lilly holds the patent holder for fluoxetine that expired in August 2001.

Dr Reddy's is not in danger of losing its exclusivity. Since DRL has already won the case against the patent holder, EIi Lilly, earlier this year, this lawsuit should be fairly easier to go through. This is the second time that DRL has suffered a setback in the past three weeks as recently Novartis withdrew from developing its licensed anti-diabetes molecule to Novo Nordisk that had been sub-licensed to Novartis.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
i want more information about prozac patent litigation
guest Saturday, January 14, 2006

You May Also Like

View All

More News on: